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Abstract. Background/Aim: Etiopathogenesis of autism
spectrum disorders (ASD) remains to be elucidated.
Congenital infections, particularly viral infections, have
repeatedly been associated with the onset of such disorders.
Our study aimed at assessing the prevalence of herpes
simplex type 1 and 2 (HSV1/2) congenital infections in
patients with ASD. Materials and Methods: In our case–
control study, a total of 38 children with ASD were compared
to 44 age- and sex-matched controls regarding the presence
of HSV1/2 infection though viral DNA polymerase chain
reaction performed on dried blood spots collected at birth.
Results: No HSV congenital infection was detected in either
group. Conclusion: Our negative finding is in agreement
with other studies that failed to demonstrate a definitive role
of HSV on the onset of ASD. Further investigation of
congenital HSV prevalence in larger and more powerful
studies is needed to undeniably discard a role of such virus
in the etiopathogenesis of ASD. 
The autism spectrum disorders (ASD) are a range of
developmental disorders defined by a deficit in social
interaction, and a narrow and repetitive pattern of interests,
behavior and activities (1). It is estimated that the prevalence
of ASD is increasing, having reached about 1.5% in
developed countries, with a male-female ratio of 4:1 (2). 
Only in a minority of cases, is a definite etiology
identified (e.g. fragile X syndrome, neurofibromatosis,
tuberous sclerosis, Timothy syndrome, exposure to
thalidomide) (3-5). The majority of ASD cases (about 85%)
are defined as idiopathic (i.e. without a definite etiological
agent) (6). In these cases, it is generically said that it derives
from an interaction between genetic and environmental
factors. Consequently, in the absence of a causative agent,
no preventative measure nor etiological treatment is available
for ASD.
However, recent studies have demonstrated that some core
symptoms of ASD can be selectively targeted using
neuromodulation treatments, such as transcranial direct
current stimulation (7), a technique which has already been
proven to be effective in other neuropsychiatric disorders
possibly arising in childhood, such as depression (8) and
obsessive-compulsive disorder (9).
In an attempt to identify the etiological agents of ASD,
several studies have been carried out to evaluate a role of
infections (10-12), but none of these provided definite
conclusions. 
Our group has proposed that ASD (or at least some cases)
may be due to a deranged immune response in children with
a genetic and environmental/lifestyle (e.g. vitamin D deficit)-
induced susceptibility to autoimmunity which is triggered by
a viral infection and leads to the impairment of specific areas
in the central nervous system (13).
Some authors have reported clinical cases of congenital
herpes simplex virus (HSV) infection in patients diagnosed
with ASD (14, 15). A few studies evaluated the prevalence
of antibodies to HSV in children with ASD but obtained
discordant results (16, 17). 
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All the studies performed so far evaluated specific
antibody prevalence in individuals with ASD. However, this
type of study does not allow the time-point of contact
between the virus and the patient to be specified. Moreover,
several studies have pointed out that a key point in ASD
development is during intrauterine life or at birth (2, 13).
Investigation of dried blood spot (DBS) in viral disease
management has found several applications and DBS
routinely collected at birth allow the diagnoses of viral
congenital infection even years later. Previously, analysis of
HSV DNA in DBS has been evaluated in retrospectively
studies, showing a highly diagnostic concordance with
standard testing and a limit of detection comparable to that
of cytomegalovirus DNA in DBS (18, 19). The aim of this
study was to evaluate the rate of congenital HSV1 and -2
infection assessed via detection of viral genome in DBS by
polymerase chain reaction (PCR) in children with ASD and
healthy controls. 
Materials and Methods
Patients. Patients admitted to the Child and Adolescent
Neuropsychiatry Unit at the Second University of Naples and to
the Department of Pediatrics at the Federico II University of
Naples between January 2010 and January 2013 were enrolled.
Informed consent was obtained from children’s parents or from
authorized representatives. The Ethics Committee of the Federico
II University of Naples approved the study (protocol number:
85/09). Inclusion criteria for cases were diagnosis of ASD
according to the Diagnostic and Statistical Manual of Mental
Disorders, Fourth edition, Text Revision (DSM-IV-TR) (20) and
confirmed by DSM-5 criteria; individuals were excluded if their
parents/representative were unable or unwilling to sign the
informed consent form. 
Controls were recruited at the Division of Pediatric Surgery of
Federico II University where they were admitted for minor surgical
treatments, or at a general pediatrician in Torre del Greco, Naples,
Italy where they went for routine check-up. All controls underwent
an interview to rule out any possible neuropsychiatric disorder. 
Neuropsychiatric evaluation. A skilled clinician administered
Griffiths Mental Development Scales (GMDS-ER) (17) and a
revised algorithm of Autism Diagnostic Observation Schedule
(ADOS) (18-20) to all cases. Patients’ parents or guardians
underwent an Autism Diagnostic Interview, Revised version (ADI-
R) (21), Childhood Autism Rating Scales (CARS) (22) and Vineland
Adaptive Behaviour Scales (VABS) (23). 
The evaluation allowed three groups of patients to be identified
based on ASD severity, defined according to DSM-5 criteria as
specified below: Level 1 (individuals that need support to have
adequate adaptation), Level (individuals that need significant
support to have adequate adaptation), Level 3 (individuals that need
very significant support to have an adequate adaptation). 
Specific congenital disorders are screened in Italy through blood
collection as DBS. Screening is carried out on every newborn at 2-
5 days of age and specimens are stored at room temperature and are
not exposed to light.
Virological tests. To analyze viral DNA in DBS, one spot was
punched manually into 35 μl of Minimum Essential Medium. Each
spot measured 3 mm in diameter, corresponding with approximately
5 μl dried blood. For each patient, three spots were with utilized to
guarantee triplicate analyses. DNA was extracted by heat treatment;
following 1-hour incubation at 55˚C, samples were kept at 100˚C
for 7 min and were then spun at 11,200 × g in order to clarify the
supernatants, which were then frozen at −80˚C overnight (21). To
confirm DNA extraction from DBS, a house-keeping gene was
amplified with a PCR designed to target human β-globin with
primers GH20 and PCO4 (22). If human β-globin was detected from
DBS, the following test on HSV-DNA was carried out; otherwise,
the whole extraction process was repeated. DNA of HSV1 and
HSV2 was amplified using nested-PCR targeting a region in the
glycoprotein D and one in the glycoprotein G gene of HSV1 and
HSV2, respectively (23). The products of nested-PCR were
recognized by agarose (2%) gel electrophoresis. 
A patient was considered positive for HSV1/2 when at least two
out of the three tests were positive for HSV-DNA, whereas if only
one of the three tests was positive, a new series of punches were
repeated from the DBS. Negative and positive controls for HSV
were included in all nested-PCR runs. To avoid cross-contamination,
strictly controlled measures were followed: the punch was washed
with ethanol and flamed between one DBS punch and the next;
moreover, after the 3-series spots were taken from one patient,
punching from unsoiled paper was performed as a negative control
throughout the study series. 
Statistical analysis. Kolmogorov–Smirnov test was applied to
quantitative continuous variables to assess for Gaussian
distribution. If this was the case, data are presented as the
mean±standard deviation (SD). Data distributed in a non-Gaussian
fashion are given as the median and interquartile range (IQR). The
same form of presentation was used for non-continuous
quantitative variables (e.g. neuropsychiatric severity scores).
Student’s t-test was used for unpaired variables and Mann–
Whitney U-test for comparison of Gaussian or non-Gaussian
distributed quantitative variables, respectively. For comparison of
qualitative variables, the chi-squared test (or Fisher’s exact test if
appropriate) was used. Statistical analysis was performed using the
Statistical Package for the Social Sciences version 18.0 (SPSS Inc.
Chicago, IL, USA).
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Table I. Main clinical scores of children with autism spectrum disorders.
Data are given as median and interquartile range.
Scale                                                                             Score
GMDS (Developmental quotient)                           50 (43-59)
VABS (Adaptive quotient)                                      50 (38-58)
ADOS (Language)                                                     5 (4-6)
ADOS (Interaction)                                                 11 (8-12)
ADOS (Total score)                                                 16 (13-18)
CARS (Total score)                                                 36 (33-40)
GMDS: Griffith Mental Developmental Scales; VABS: Vineland
Adaptive Behavior Scales; ADOS: Autism Diagnostic Observation
Schedule; CARS: Childhood Autism Rating Scales.
Results
A total of 82 children (38 with ASD and 44 healthy controls)
were and evaluated. Main demographic and clinical features
of children with ASD are reported in Table I. The mean age
of children with ASD was higher than that of controls (5±1.3
years vs. 4±1.7 years, respectively, p=0.007). The male/female
ratio was similar in cases and in controls (76.3% vs. 68.2%,
p=0.414).
Children with ASD had the following median gravity
scores: ADOS total score 17 (IQR=15-20), GMDS
(Developmental quotient) 54 (IQR =35-62), VABS (Adaptive
quotient) 51 (IQR=40-63), CARS total score 37 (IQR=33-
40). Most patients had a gravity score of 3 (55%), whereas
35% had a gravity score of 2 and 10% of 1.
No DBS in the two cohorts was positive for HSV1 or
HSV2 DNA.
Discussion
Our study shows that no children with ASD as well as none
of the controls had a congenital HSV1 or 2 infection as
assessed through viral genome detection on DBS collected
at birth.
Notably, the interval between the sampling and onset of
illness is the most important factor for a positive result of an
HSV-DNA assay. A retrospective study led on DBS from 28
children with neonatal HSV infection showed that viremia
may be present up to 5 days before and 6 days after the onset
of neonatal herpes (19). It has been hypothesized that a child
with disseminated disease and shorter incubation time more
often has an HSV-DNA-positive DBS card than a child with
later onset of symptoms (often encephalitis): this finding
may support the role of the neuronal route of transmission
in such later onset disease. In previous serological studies,
DBS were compared with serum samples and comparable
specificity and sensitivity were obtained, and more than one
group of researchers had validated the use of DBS for both
HSV antibody and DNA detection (18, 19, 24).
Our negative finding is in agreement with other studies
which, using different methods, came to the same
conclusion: no role of HSV is currently demonstrated in the
etiology of ASD (16, 25). We previously showed that
children with ASD had a similar anti-HSV rate compared to
healthy same-aged controls (25).
However, biological plausibility of HSV as an agent of
neurocognitive disorders does exist. In fact, belonging to the
Herpesviridae family, this virus therefore has a tropism for the
central nervous system. Moreover, these viruses are suspected
to act as triggers of a series of autoimmune disorders as they
can interact with the immune system (26-28).
Mora et al. found a higher rate of anti-HSV IgM in
children with ASD than in healthy controls (17). Moreover,
a recent study conducted in Norway found that high levels
of HSV-2 IgG antibodies collected in maternal midpregnancy
plasma were associated with increased risk of ASD in male
offspring (29). 
We acknowledge that our study has the following main
limitations: i) the small sample size does not allow for a
conclusive answer to be given to the question of a possible role
of HSV even only in a subset of patients with ASD, as HSV
congenital infection is rare [between 1.6 and 60 per 100,000
live births in the general population (30)] and therefore an
etiological role of HSV cannot be completely excluded in some
cases; ii) the virus could act via ‘a hit and run’ strategy and
therefore it could have triggered a cascade of events during
intrauterine life irrespectively of its undetectability at birth. In
this light, a recent study found that HSV1 interacts and
modifies the expression of several human genes such that it
creates a host/pathogen ‘interactome’ of 1,347 genes (31).
These genes might be involved in modulating the risk of
several diseases such as schizophrenia or autism (31).
In conclusion, rate of congenital HSV infection assessed
through viral genome detection on DBS collected at birth
was found to be zero in a small cohort of patients with ASD.
However, the biological plausibility of HSV as an agent of
neurocognitive disorders exists. Larger and more powerful
studies are needed in order to evaluate the reliability of these
findings and definitely discard a role of HSV in the etiology
of ASD. 
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